BTZ used at a concentration of 5 nmol/L along with ATO (1 μmol/L), induced MCL cell apoptosis to the same extent as a treatment by 7.5 nmol/L BTZ alone (P > 0.05). The gene discussed is CASC3; the disease is mantle cell lymphoma.